Superior peptides represent the highest quality research compounds available, with our Elamipretide (SS-31) standing as a prime example of pharmaceutical-grade purity. This mitochondrial-targeting peptide has shown potential in addressing mitochondrial dysfunction through its unique mechanism of action.
Elamipretide (MTP-131, SS-31, D-Arg-Dmt-Lys-Phe-NH2) functions as an inhibitor of cytochrome c peroxidase. Our superior peptides undergo rigorous quality control to ensure consistent performance in research applications. The compound has demonstrated ability to improve mitochondrial dysfunction and synaptic impairment in preclinical studies.
As a leading manufacturer of superior peptides, we offer Elamipretide in various research-grade quantities. The product appears as a white lyophilized powder with purity exceeding 99%, making it ideal for scientific investigation. Our facility maintains strict GMP compliance to guarantee the highest standards in peptide production.
The superior peptides we produce, including this SS-31 variant, are provided exclusively for laboratory research purposes. Researchers value these compounds for their potential applications in studying metabolic regulation and cellular protection mechanisms. Each batch undergoes comprehensive analytical testing to verify identity, purity, and stability.
Our superior peptides portfolio includes this mitochondrial-targeting compound along with various other research-grade peptides. The production process utilizes advanced synthesis and purification technologies to achieve pharmaceutical-grade quality. We welcome third-party verification of our products' specifications and performance characteristics.